Get a glimpse into our company and investor data—powered by the PitchBook Platform
Portfolio of diclofenac products. The portfolio comprises of Cambia a diclofenac potassium for oral consumption used for the treatment of acute migraine headache pain.
This information is reserved for PitchBook Platform users. To explore Kowa Pharmaceuticals America (Diclofenac Products)‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.